Rivus Pharmaceuticals Inc., a clinical-stage biopharmaceutical company dedicated to improving cardio-metabolic health, announced the completion of a $132 million Series B financing led by...
Orna Therapeutics, a biotechnology company pioneering a new class of fully engineered circular RNA therapies (oRNA), announced the initial closing of its $221 million...
Delfi Diagnostics, Inc., a pioneering developer of a new class of high-performance, accessible liquid biopsy tests for early cancer detection and monitoring, announced a...
Mojia Biotech, a Shanghai-based leading bio-manufacturing company dedicated to sustainable development and carbon neutrality, announced the completion of an $80 million Series B Financing....
moa Technology Limited, the crop protection discovery company that is revolutionizing the future of weed control in agriculture, announced that it has secured $44m...
